Primary Site >> Esophagus Cancer
Gene >> PLK1
| 1. | |||||||||||
| Journal: | Int J Oncol. 1999 Oct;15(4):687-92. | ||||||||||
| Title: | Prognostic significance of polo-like kinase expression in esophageal carcinoma. | ||||||||||
| Author: | Tokumitsu, Y|Mori, M|Tanaka, S|Akazawa, K|Nakano, S|Niho, Y | ||||||||||
| PMID: | 10493949 | ||||||||||
| 2. | |||||||||||
| Journal: | Oncogene. 2002 May 9;21(20):3162-71. | ||||||||||
| Title: | Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells. | ||||||||||
| Author: | Spankuch-Schmitt, Birgit|Wolf, Georg|Solbach, Christine|Loibl, Sibylle|Knecht, Rainald|Stegmuller, Manfred|von Minckwitz, Gunter|Kaufmann, Manfred|Strebhardt, Klaus | ||||||||||
| PMID: | 12082631 | ||||||||||
| 3. | |||||||||||
| Journal: | Oncogene. 2005 Jan 10;24(2):287-91. | ||||||||||
| Title: | Polo-like kinases (Plks) and cancer. | ||||||||||
| Author: | Takai, Noriyuki|Hamanaka, Ryoji|Yoshimatsu, Jun|Miyakawa, Isao | ||||||||||
| PMID: | 15640844 | ||||||||||
| 4. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2006 Apr 7;342(2):465-71. Epub 2006 Feb 9. | ||||||||||
| Title: | Polo-like kinase and survivin are esophageal tumor-specific promoters. | ||||||||||
| Author: | Sato, Fumiaki|Abraham, John M|Yin, Jing|Kan, Takatsugu|Ito, Tetsuo|Mori, Yuriko|Hamilton, James P|Jin, Zhe|Cheng, Yulan|Paun, Bogdan|Berki, Agnes T|Wang, Suna|Shimada, Yutaka|Meltzer, Stephen J | ||||||||||
| PMID: | 16487489 | ||||||||||
| 5. | |||||||||||
| Journal: | J Thorac Cardiovasc Surg. 2007 Mar;133(3):763-9. | ||||||||||
| Title: | Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model. | ||||||||||
| Author: | Bonde, Pramod|Sui, Guoping|Dhara, Surajit|Wang, Jiaai|Broor, Apoorv|Kim, Irene F|Wiley, John E|Marti, Guy|Duncan, Mark|Jaffee, Elizabeth|Montgomery, Elizabeth|Maitra, Anirban|Harmon, John W | ||||||||||
| PMID: | 17320581 | ||||||||||
| 6. | |||||||||||
| Journal: | Oncology. 2008;74(3-4):198-206. | ||||||||||
| Title: | Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells. | ||||||||||
| Author: | Bu, Youquan|Yang, Zhengmei|Li, Quanhai|Song, Fangzhou | ||||||||||
| PMID: | 18714168 | ||||||||||
| 7. | |||||||||||
| Journal: | Int J Cancer. 2011 Nov 1;129(9):2134-46. | ||||||||||
| Title: | Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer. | ||||||||||
| Author: | Ito, Tetsuo|Sato, Fumiaki|Kan, Takatsugu|Cheng, Yulan|David, Stefan|Agarwal, Rachana|Paun, Bogdan C|Jin, Zhe|Olaru, Alexandru V|Hamilton, James P|Selaru, Florin M|Yang, Jian|Matsumura, Nobutoshi|Shimizu, Kazuharu|Abraham, John M|Shimada, Yutaka|Mori, Yuri | ||||||||||
| PMID: | 21170987 | ||||||||||
| 8. | |||||||||||
| Journal: | Clin Cancer Res. 2011 May 15;17(10):3420-30. | ||||||||||
| Title: | Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies. | ||||||||||
| Author: | Olmos, David|Barker, Douglas|Sharma, Rohini|Brunetto, Andre T|Yap, Timothy A|Taegtmeyer, Anne B|Barriuso, Jorge|Medani, Hanine|Degenhardt, Yan Y|Allred, Alicia J|Smith, Deborah A|Murray, Sharon C|Lampkin, Thomas A|Dar, Mohammed M|Wilson, Richard|de Bono, | ||||||||||
| PMID: | 21459796 | ||||||||||
| 9. | |||||||||||
| Journal: | Clin Cancer Res. 2011 Jul 1;17(13):4285-95. | ||||||||||
| Title: | PLK1 Is transcriptionally activated by NF-kappaB during cell detachment and enhances anoikis resistance through inhibiting beta-catenin degradation in esophageal squamous cell carcinoma. | ||||||||||
| Author: | Lin, De-Chen|Zhang, Yu|Pan, Qin-Jing|Yang, Hai|Shi, Zhi-Zhou|Xie, Zhi-Hui|Wang, Bo-Shi|Hao, Jia-Jie|Zhang, Tong-Tong|Xu, Xin|Zhan, Qi-Min|Wang, Ming-Rong | ||||||||||
| PMID: | 21610149 | ||||||||||
| 10. | |||||||||||
| Journal: | Gastroenterology. 2012 Mar;142(3):521-530.e3. | ||||||||||
| Title: | Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells. | ||||||||||
| Author: | Zhang, Yu|Du, Xiao-Li|Wang, Cheng-Ji|Lin, De-Chen|Ruan, Xia|Feng, Yan-Bin|Huo, Yan-Qiu|Peng, Haiyong|Cui, Jing-Lu|Zhang, Tong-Tong|Wang, Yong-Quan|Zhang, Hongbing|Zhan, Qi-Min|Wang, Ming-Rong | ||||||||||
| PMID: | 22108192 | ||||||||||
| 11. | |||||||||||
| Journal: | J Med Food. 2013 Oct;16(10):869-77. | ||||||||||
| Title: | Moscatilin induces apoptosis and mitotic catastrophe in human esophageal cancer cells. | ||||||||||
| Author: | Chen, Chien-An|Chen, Chien-Chih|Shen, Chien-Chang|Chang, Hen-Hong|Chen, Yu-Jen | ||||||||||
| PMID: | 24074296 | ||||||||||
| 12. | |||||||||||
| Journal: | Mutat Res Rev Mutat Res. 2014 Mar 12. pii: S1383-5742(14)00019-2. | ||||||||||
| Title: | Plk1-targeted therapies in TP53- or RAS-mutated cancer. | ||||||||||
| Author: | Yim, Hyungshin|Erikson, Raymond L | ||||||||||
| PMID: | 24630986 | ||||||||||
| 13. | |||||||||||
| Journal: | Mol Med Rep. 2014 Oct;10(4):2099-104. | ||||||||||
| Title: | miR210 regulates esophageal cancer cell proliferation by inducing G2/M phase cell cycle arrest through targeting PLK1. | ||||||||||
| Author: | Li, Chenglin|Zhou, Xinliang|Wang, Yadi|Jing, Shaowu|Yang, Congrong|Sun, Guogui|Liu, Qing|Cheng, Yunjie|Wang, Lan | ||||||||||
| PMID: | 25069478 | ||||||||||
| 14. | |||||||||||
| Journal: | Am J Transl Res. 2017 Aug 15;9(8):3741-3748. eCollection 2017. | ||||||||||
| Title: | Association of ECRG4 with PLK1, CDK4, PLOD1 and PLOD2 in esophageal squamous cell carcinoma. | ||||||||||
| Author: | Li, Linwei|Wang, Wenyu|Li, Xiaoyan|Gao, Tianhui | ||||||||||
| PMID: | 28861165 | ||||||||||
| 15. | |||||||||||
| Journal: | Cell Death Dis. 2018 Jan 16;9(2):17. | ||||||||||
| Title: | Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling. | ||||||||||
| Author: | Cao, Ying-Ya|Yu, Jing|Liu, Ting-Ting|Yang, Kai-Xia|Yang, Li-Yan|Chen, Qun|Shi, Feng|Hao, Jia-Jie|Cai, Yan|Wang, Ming-Rong|Lu, Wei-Hua|Zhang, Yu | ||||||||||
| PMID: | 29339720 | ||||||||||
| 16. | |||||||||||
| Journal: | Toxicol Appl Pharmacol. 2018 Jun 1;348:76-84. | ||||||||||
| Title: | The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma. | ||||||||||
| Author: | Gu, Meng-Meng|Li, Ming|Gao, Dexuan|Liu, Lang-Huan|Lang, Yue|Yang, Si-Ming|Ou, Hongling|Huang, Bo|Zhou, Ping-Kun|Shang, Zeng-Fu | ||||||||||
| PMID: | 29679654 | ||||||||||